Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind Sham-controlled Trial of High Frequency rTMS for Cognitive Impairments in Chronic Schizophrenia Patients

NCT03774927 is registered in ClinicalTrials.gov with Beijing HuiLongGuan Hospital as lead sponsor.

NCT NCT03774927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03774927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind Sham-controlled Trial of High Frequency rTMS for Cognitive Impairments in Chronic Schizophrenia Patients
Lead sponsor
Beijing HuiLongGuan Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2017
Completion date
November 30, 2018
Enrollment
120 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia